These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3576521)

  • 1. Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1 alpha excretion in healthy subjects.
    Kallmann R; Nieuwenhuis HK; de Groot PG; van Gijn J; Sixma JJ
    Thromb Res; 1987 Feb; 45(4):355-61. PubMed ID: 3576521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
    Gerrard JM; Taback S; Singhroy S; Docherty JC; Kostolansky I; McNicol A; Kobrinsky NL; McKenzie JK; Rowe R
    Circulation; 1989 Jan; 79(1):29-38. PubMed ID: 2910545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension.
    Benigni A; Gregorini G; Frusca T; Chiabrando C; Ballerini S; Valcamonico A; Orisio S; Piccinelli A; Pinciroli V; Fanelli R
    N Engl J Med; 1989 Aug; 321(6):357-62. PubMed ID: 2664523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of exercise on bleeding time and local production of prostacyclin and thromboxane.
    Carter JW; Ready AE; Singhroy S; Duta E; Gerrard JM
    Eur J Appl Physiol Occup Physiol; 1989; 59(5):355-9. PubMed ID: 2513183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
    Kyrle PA; Eichler HG; Jäger U; Lechner K
    Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of two low doses of aspirin on whole blood thromboxane and prostacyclin generation in healthy subjects.
    Davì G; Custro N; Novo S; Mattina A; Strano A
    Thromb Haemost; 1983 Oct; 50(3):669-70. PubMed ID: 6417815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2 in skin-bleeding-time blood and in clotted venous blood before and after administration of acetylsalicylic acid.
    Thorngren M; Shafi S; Born GV
    Lancet; 1983 May; 1(8333):1075-8. PubMed ID: 6133107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of regular and enteric-coated aspirin on bleeding time, thromboxane, and prostacyclin.
    Gow JA; Ebbeling L; Gerrard JM
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jul; 49(1):515-20. PubMed ID: 8361987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
    Tohgi H; Konno S; Tamura K; Kimura B; Kawano K
    Stroke; 1992 Oct; 23(10):1400-3. PubMed ID: 1412574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin.
    Vial JH; McLeod LJ; Roberts MS; Seville PR
    Aust N Z J Med; 1990 Oct; 20(5):652-6. PubMed ID: 2126726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term ultra-low-dose aspirin therapy and platelet function.
    Chetty N; Atkinson PM; Bradlow BA
    S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1 gram oral or intravenous aspirin on urinary excretion of thromboxane B2 and 6-keto-PGF1 alpha in healthy subjects.
    Bucchi F; Bodzenta A; de Gaetano G; Cerletti C
    Prostaglandins; 1986 Nov; 32(5):691-701. PubMed ID: 3103169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
    Knapp HR; Reilly IA; Alessandrini P; FitzGerald GA
    N Engl J Med; 1986 Apr; 314(15):937-42. PubMed ID: 3007982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in patients with bleeding disorders show that platelet-vessel interaction is important for thromboxane formation in bleeding time wounds.
    Gerrard JM; Singhroy S; Duta E; Nosek-Cenkowska B; Israels SJ; Israels ED
    Thromb Res; 1990 Oct; 60(1):79-85. PubMed ID: 2278038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
    Ylikorkala O; Mäkilä UM; Viinikka L
    Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal.
    Vial JH; McLeod LJ; Roberts MS
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():157-60. PubMed ID: 1825534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.